Got Alzheimers?

 

 

GOT A​ LZHEIMERS? 

An Informational pamphlet on what you need to know
ASAP

 
 
 

CREATED BY LILY STOCKER  

 

2 
 

A GLOBAL EPIDEMIC 
----X

With 35 million being affected by Alzheimer's Disease (AD) 
globally every year, and the number expected to grow to 135 million by 
2050, AD is a growing epidemic that needs to be resolved (Integrative 
Medicine). 

 

 

 

3 
 

“ 

“You have your good days, your bad days and your Alzheimer's days," he says, 
"I could wake up in the morning, get dressed, go into the kitchen—then my 
world falls apart, I lose all concept of what I'm doing and what I'm supposed 

to be doing.”  

-AZ PATIENT (AGING CARE) 

” 

A PRICEY  
- - - - X 

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam 
nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat 
volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation 
ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. 

 
 

4 

 
 

 

CAUSES OF AZ INCLUDE SMOKING, 
AGE, AND GENETICS 

THE RISK FACTORS  
----X

 
The Epidemiology of Alzheimer's Disease, “socio-demographic 
factors such as gender, educational level, marital status seem 
to be major risk factors of AD in old age with a similar 
magnitude as genetic factors like apoE4 allele.” Even if the 
concept of socioeconomic level or marital status seems to be far 
fetched, it is viable to note that these discoveries and 
correlations are being made, bringing us closer to a cure or 
prevention. A genetic predisposition also seems to be an 
indicator of developing AD, “In patients with relatively early 
onset of AD, familial factors may explain 75-81% of the disease 
in the exposed, that is in those with a positive family history”  

 
 
 

 

5 

 
 

 
 

BILOGICAL STANDPOINT 
- - - - X 

In the 1980s it was discovered that “dementia is associated with 
more than 70 different causes of brain dysfunction, AD is the most 
common cause accounting for roughly half of all cases” (Cambridge). 
Within the past twenty years, there have been progressions with 
neuroimaging which measures the hippocampal, cortical, and general 
brain atrophy (Cambridge). Findings from these technological 
developments demonstrate that AD starts by destroying neuron 
connections that help with memory, then the entorhinal cortex and 
hippocampus. Eventually, it affects most of the brains outer layer. 
This destruction of cells is widespread and eventually leads to death 
(NIH). Progressions regarding how to treat the disease are being 
researched and developed, however, it is emphasized that it is 
critical to identify early onset of the disease, that way experts can 
possibly predict the patient's decline (NIH).  

 
 

 

6